Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M de Roos

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Plos One|August 31, 2023
Using individual-based bioenergetic models to predict the aggregate effects of disturbance on populations: A case study with beaked whales and Navy sonarVincent Hin, André M de Roos, Kelly J Benoit-Bird, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 20, 2023
Effects of correcting metabolic acidosis on muscle mass and functionality in chronic kidney disease: a systematic review and meta-analysisWesley J Visser, Elma E M van de Braak, Anneke M E de Mik-van Egmond, et al.
Molecular Cancer Therapeutics|November 2, 2018
Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017Joost C M Uitdehaag, Jeffrey J Kooijman, Jeroen A D M de Roos, et al.
Oncotarget|April 19, 2017
Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell linesMarion A A Libouban, Jeroen A D M de Roos, Joost C M Uitdehaag, et al.
BMJ Open|May 26, 2026
Effectiveness of an anti-inflammatory diet intervention and cognitive behavioural therapy in endometriosis: protocol for a randomised controlled clinical trialEmma Huijs, Loutje van der Sman, Lieke Wirken, et al.
Journal of Molecular Biology|May 26, 2017
Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative ActivityJoost C M Uitdehaag, Jos de Man, Nicole Willemsen-Seegers, et al.
Molecular Cancer Therapeutics|September 3, 2016
Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 InhibitorsJoost C M Uitdehaag, Jeroen A D M de Roos, Martine B W Prinsen, et al.
Frontiers in Oncology|October 3, 2022
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020Jeffrey J Kooijman, Wilhelmina E van Riel, Jelle Dylus, et al.
BMJ Open|December 30, 2025
Effectiveness of protein supplementation combined with resistance training to counteract disproportional fat-free mass loss following metabolic bariatric surgery: rationale and design of the ENRICHED randomised controlled trialBente M de Roos, Lin-Lin Yessica Yeh, Puck S van den Hooff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2015
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer modelA R R Maia, J de Man, U Boon, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Plos One|August 31, 2023
Using individual-based bioenergetic models to predict the aggregate effects of disturbance on populations: A case study with beaked whales and Navy sonarVincent Hin, André M de Roos, Kelly J Benoit-Bird, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 20, 2023
Effects of correcting metabolic acidosis on muscle mass and functionality in chronic kidney disease: a systematic review and meta-analysisWesley J Visser, Elma E M van de Braak, Anneke M E de Mik-van Egmond, et al.
Molecular Cancer Therapeutics|November 2, 2018
Combined Cellular and Biochemical Profiling to Identify Predictive Drug Response Biomarkers for Kinase Inhibitors Approved for Clinical Use between 2013 and 2017Joost C M Uitdehaag, Jeffrey J Kooijman, Jeroen A D M de Roos, et al.
Oncotarget|April 19, 2017
Stable aneuploid tumors cells are more sensitive to TTK inhibition than chromosomally unstable cell linesMarion A A Libouban, Jeroen A D M de Roos, Joost C M Uitdehaag, et al.
BMJ Open|May 26, 2026
Effectiveness of an anti-inflammatory diet intervention and cognitive behavioural therapy in endometriosis: protocol for a randomised controlled clinical trialEmma Huijs, Loutje van der Sman, Lieke Wirken, et al.
Journal of Molecular Biology|May 26, 2017
Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative ActivityJoost C M Uitdehaag, Jos de Man, Nicole Willemsen-Seegers, et al.
Molecular Cancer Therapeutics|September 3, 2016
Cell Panel Profiling Reveals Conserved Therapeutic Clusters and Differentiates the Mechanism of Action of Different PI3K/mTOR, Aurora Kinase and EZH2 InhibitorsJoost C M Uitdehaag, Jeroen A D M de Roos, Martine B W Prinsen, et al.
Frontiers in Oncology|October 3, 2022
Comparative kinase and cancer cell panel profiling of kinase inhibitors approved for clinical use from 2018 to 2020Jeffrey J Kooijman, Wilhelmina E van Riel, Jelle Dylus, et al.
BMJ Open|December 30, 2025
Effectiveness of protein supplementation combined with resistance training to counteract disproportional fat-free mass loss following metabolic bariatric surgery: rationale and design of the ENRICHED randomised controlled trialBente M de Roos, Lin-Lin Yessica Yeh, Puck S van den Hooff, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2015
Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer modelA R R Maia, J de Man, U Boon, et al.
Pageof 18